ROCKY BRANDS, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that ROCKY BRANDS, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $75.34M | Mar 6, 2020 |
| FY2019 | Sep 30, 2019 | $67.18M | Mar 6, 2020 |
| FY2019 | Jun 30, 2019 | $61.96M | Mar 6, 2020 |
| FY2019 | Mar 31, 2019 | $65.93M | Mar 6, 2020 |
| FY2019 | Dec 31, 2018 | $67.19M | Mar 6, 2020 |
| FY2019 | Sep 30, 2018 | $65.92M | Mar 6, 2020 |
| FY2019 | Jun 30, 2018 | $58.21M | Mar 6, 2020 |
| FY2019 | Mar 31, 2018 | $61.39M | Mar 6, 2020 |
| FY2018 | Dec 31, 2017 | $66.99M | Mar 13, 2019 |
| FY2018 | Sep 30, 2017 | $64.68M | Mar 13, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $66.99M | Mar 12, 2018 |
| FY2017 | Sep 30, 2017 | $64.68M | Mar 12, 2018 |
| FY2017 | Jun 30, 2017 | $58.45M | Mar 12, 2018 |
| FY2017 | Mar 31, 2017 | $63.07M | Mar 12, 2018 |
| FY2017 | Dec 31, 2016 | $66.95M | Mar 12, 2018 |
| FY2017 | Sep 30, 2016 | $73.22M | Mar 12, 2018 |
| FY2017 | Jun 30, 2016 | $62.56M | Mar 12, 2018 |
| FY2017 | Mar 31, 2016 | $57.53M | Mar 12, 2018 |
| FY2016 | Dec 31, 2015 | $65.27M | Mar 9, 2017 |
| FY2016 | Sep 30, 2015 | $70.00M | Mar 9, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $197.29M | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | $179.01M | Mar 11, 2026 |
| FY2024 | Dec 31, 2023 | $178.60M | Mar 17, 2025 |
| FY2024 | Dec 31, 2022 | $225.22M | Mar 17, 2025 |
| FY2023 | Dec 31, 2021 | $194.54M | Mar 15, 2024 |
| FY2020 | Dec 31, 2020 | $36.12M | Mar 16, 2021 |
| FY2020 | Sep 30, 2020 | $29.83M | Mar 16, 2021 |
| FY2020 | Jun 30, 2020 | $19.46M | Mar 16, 2021 |
| FY2020 | Mar 31, 2020 | $19.32M | Mar 16, 2021 |
| FY2020 | Dec 31, 2019 | $28.25M | Mar 16, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.27M | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | $11.39M | Mar 11, 2026 |
| FY2024 | Dec 31, 2023 | $10.43M | Mar 17, 2025 |
| FY2024 | Dec 31, 2022 | $20.47M | Mar 17, 2025 |
| FY2023 | Dec 31, 2021 | $20.56M | Mar 15, 2024 |
| FY2020 | Dec 31, 2020 | $9.72M | Mar 16, 2021 |
| FY2020 | Sep 30, 2020 | $7.61M | Mar 16, 2021 |
| FY2020 | Jun 30, 2020 | $2.44M | Mar 16, 2021 |
| FY2020 | Mar 31, 2020 | $1.19M | Mar 16, 2021 |
| FY2020 | Dec 31, 2019 | $5.09M | Mar 16, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $37.19M | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | $31.07M | Mar 11, 2026 |
| FY2024 | Dec 31, 2023 | $35.37M | Mar 17, 2025 |
| FY2024 | Dec 31, 2022 | $44.04M | Mar 17, 2025 |
| FY2023 | Dec 31, 2021 | $35.97M | Mar 15, 2024 |
| FY2022 | Dec 31, 2020 | $27.17M | Mar 10, 2023 |
| FY2020 | Dec 31, 2019 | $22.09M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $18.06M | Mar 6, 2020 |
| FY2018 | Dec 31, 2017 | $11.83M | Mar 13, 2019 |
| FY2017 | Dec 31, 2016 | ($3.06M) | Mar 12, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $68.94M | Mar 12, 2018 |
| FY2017 | Dec 31, 2016 | $75.63M | Mar 12, 2018 |
| FY2017 | Dec 31, 2015 | $78.40M | Mar 12, 2018 |
| FY2016 | Dec 31, 2014 | $80.60M | Mar 9, 2017 |
| FY2015 | Dec 31, 2013 | $71.35M | Mar 3, 2016 |
| FY2014 | Dec 31, 2012 | $66.68M | Feb 27, 2015 |
| FY2013 | Dec 31, 2011 | $69.85M | Mar 6, 2014 |
| FY2012 | Dec 31, 2010 | $72.30M | Mar 4, 2013 |
| FY2011 | Dec 31, 2009 | $75.07M | Feb 28, 2012 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.30M | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | $52.76M | Mar 11, 2026 |
| FY2024 | Dec 31, 2023 | $73.58M | Mar 17, 2025 |
| FY2024 | Dec 31, 2022 | $19.12M | Mar 17, 2025 |
| FY2023 | Dec 31, 2021 | ($54.88M) | Mar 15, 2024 |
| FY2022 | Dec 31, 2020 | $31.44M | Mar 10, 2023 |
| FY2020 | Dec 31, 2019 | $18.09M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $17.57M | Mar 6, 2020 |
| FY2018 | Dec 31, 2017 | $17.11M | Mar 13, 2019 |
| FY2017 | Dec 31, 2016 | $21.30M | Mar 12, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.58M | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | $4.66M | Mar 11, 2026 |
| FY2024 | Dec 31, 2023 | $3.92M | Mar 17, 2025 |
| FY2024 | Dec 31, 2022 | $6.70M | Mar 17, 2025 |
| FY2023 | Dec 31, 2021 | $21.06M | Mar 15, 2024 |
| FY2022 | Dec 31, 2020 | $11.72M | Mar 10, 2023 |
| FY2020 | Dec 31, 2019 | $7.72M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $4.24M | Mar 6, 2020 |
| FY2018 | Dec 31, 2017 | $4.31M | Mar 13, 2019 |
| FY2017 | Dec 31, 2016 | $5.91M | Mar 12, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $477.49M | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | $457.30M | Mar 11, 2026 |
| FY2024 | Dec 31, 2023 | $479.39M | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | $582.39M | Mar 15, 2024 |
| FY2022 | Dec 31, 2021 | $624.58M | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | $229.09M | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | $205.83M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $184.66M | Mar 6, 2020 |
| FY2018 | Dec 31, 2017 | $173.48M | Mar 13, 2019 |
| FY2017 | Dec 31, 2016 | $178.94M | Mar 12, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $225.40M | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | $225.08M | Mar 11, 2026 |
| FY2024 | Dec 31, 2023 | $255.83M | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | $366.92M | Mar 15, 2024 |
| FY2022 | Dec 31, 2021 | $426.72M | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | $49.59M | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | $41.17M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $33.09M | Mar 6, 2020 |
| FY2018 | Dec 31, 2017 | $32.39M | Mar 13, 2019 |
| FY2017 | Dec 31, 2016 | $43.85M | Mar 12, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $252.09M | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | $232.22M | Mar 11, 2026 |
| FY2025 | Dec 31, 2023 | $223.56M | Mar 11, 2026 |
| FY2024 | Dec 31, 2022 | $215.47M | Mar 17, 2025 |
| FY2024 | Dec 31, 2021 | $197.86M | Mar 17, 2025 |
| FY2023 | Dec 31, 2020 | $179.51M | Mar 15, 2024 |
| FY2022 | Dec 31, 2019 | $164.66M | Mar 10, 2023 |
| FY2020 | Dec 31, 2018 | $151.58M | Mar 16, 2021 |
| FY2019 | Dec 31, 2017 | $141.09M | Mar 6, 2020 |
| FY2018 | Dec 31, 2016 | $135.09M | Mar 13, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $47.84M | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | $47.84M | Mar 11, 2026 |
| FY2024 | Dec 31, 2023 | $47.84M | Mar 17, 2025 |
| FY2024 | Dec 31, 2022 | $50.25M | Mar 17, 2025 |
| FY2023 | Dec 31, 2021 | $50.25M | Mar 15, 2024 |
| FY2021 | Dec 31, 2020 | $0 | Mar 15, 2022 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $176.00M | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | $158.36M | Mar 11, 2026 |
| FY2024 | Dec 31, 2023 | $151.58M | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | $145.72M | Mar 15, 2024 |
| FY2022 | Dec 31, 2021 | $129.79M | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | $113.53M | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | $96.66M | Mar 16, 2021 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.90M | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | $3.72M | Mar 11, 2026 |
| FY2024 | Dec 31, 2023 | $4.47M | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | $5.72M | Mar 15, 2024 |
| FY2022 | Dec 31, 2021 | $5.91M | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | $28.35M | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | $15.52M | Mar 16, 2021 |
| FY2020 | Dec 31, 2018 | $10.17M | Mar 16, 2021 |
| FY2019 | Dec 31, 2017 | $3.68M | Mar 6, 2020 |
| FY2018 | Dec 31, 2016 | $4.48M | Mar 13, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $122.64M | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | $128.74M | Mar 11, 2026 |
| FY2024 | Dec 31, 2023 | $173.13M | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | $256.90M | Mar 15, 2024 |
| FY2022 | Dec 31, 2021 | $270.04M | Mar 10, 2023 |
| FY2013 | Dec 31, 2013 | $38.39M | Mar 6, 2014 |
| FY2013 | Dec 31, 2012 | $23.46M | Mar 6, 2014 |
| FY2012 | Dec 31, 2011 | $35.00M | Mar 4, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Mar 11, 2026 |
| FY2024 | Dec 31, 2023 | 1 | Mar 17, 2025 |
| FY2024 | Dec 31, 2022 | 2 | Mar 17, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Mar 15, 2024 |
| FY2020 | Dec 31, 2020 | 1 | Mar 16, 2021 |
| FY2020 | Sep 30, 2020 | 1 | Mar 16, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Mar 16, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Mar 16, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Mar 16, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Mar 11, 2026 |
| FY2024 | Dec 31, 2023 | 1 | Mar 17, 2025 |
| FY2024 | Dec 31, 2022 | 2 | Mar 17, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Mar 15, 2024 |
| FY2020 | Dec 31, 2020 | 1 | Mar 16, 2021 |
| FY2020 | Sep 30, 2020 | 1 | Mar 16, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Mar 16, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Mar 16, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Mar 16, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7.51M | Mar 11, 2026 |
| FY2025 | Dec 31, 2024 | 7.45M | Mar 11, 2026 |
| FY2024 | Dec 31, 2023 | 7.41M | Mar 17, 2025 |
| FY2023 | Dec 31, 2022 | 7.34M | Mar 15, 2024 |
| FY2022 | Dec 31, 2021 | 7.30M | Mar 10, 2023 |
| FY2021 | Dec 31, 2020 | 7.25M | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | 7.35M | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | 7.37M | Mar 6, 2020 |
| FY2018 | Dec 31, 2017 | 7.40M | Mar 13, 2019 |
| FY2017 | Dec 31, 2016 | 7.42M | Mar 12, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $1.02M | Mar 16, 2021 |
| FY2020 | Sep 30, 2020 | $1.02M | Mar 16, 2021 |
| FY2020 | Jun 30, 2020 | $1.02M | Mar 16, 2021 |
| FY2020 | Mar 31, 2020 | $1.03M | Mar 16, 2021 |
| FY2020 | Dec 31, 2019 | $1.03M | Mar 16, 2021 |
| FY2020 | Sep 30, 2019 | $1.04M | Mar 16, 2021 |
| FY2020 | Jun 30, 2019 | $1.04M | Mar 16, 2021 |
| FY2020 | Mar 31, 2019 | $887.0K | Mar 16, 2021 |
| FY2019 | Dec 31, 2018 | $891.0K | Mar 6, 2020 |
| FY2019 | Sep 30, 2018 | $889.0K | Mar 6, 2020 |